According to AlphaMoat, in October 2026 Ultromics (ultromics.com) received 16,013 monthly visits (-36.4% MoM) — ranked #8,160 of 17,609 AI websites with traffic data, and #1,128 of 3,112 in Industry Services; its largest market is United States (51.4% of visits).
Ultromics develops a clinically validated, FDA 510(k)-cleared AI platform (the EchoGo series) that analyzes routine echocardiograms to help identify heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis within existing workflows, supporting detection of two severely underdiagnosed diseases. The platform is in use at top U.S. hospitals.
| Month | Monthly visits | MoM |
|---|---|---|
| 2026-06 | 10.4K | — |
| 2026-07 | 19.2K | +83.8% |
| 2026-08 | 17.9K | -6.9% |
| 2026-09 | 25.2K | +40.9% |
| 2026-10 | 16.0K | -36.4% |
An AI recruiting platform unifying hiring workflows, talent relationships, and analytics.
+ CompareA platform connecting specialists with model research, training, and evaluation projects
+ CompareA conversational hiring agent that moves candidates from application through onboarding
+ CompareA talent-intelligence platform using agents to support hiring, development, and workforce deployment
+ CompareA clinician platform combining communication, telehealth, and AI-assisted documentation
+ CompareAn AI research and search platform built for professional investors
+ CompareAccording to AlphaMoat, Ultromics (ultromics.com) received 16,013 visits (about 16.0K) in October 2026 (-36.4% month over month), ranking #8,160 of 17,609 AI websites with traffic data, and #1128 in Industry Services.
In October 2026, Ultromics’s largest markets by share of visits are United States 51.4%, UK 16.6%, India 15.6%.
In Industry Services, the other products with the most monthly visits are Ashby (28.4M), Mercor (14.2M), Paradox (11.4M), Eightfold AI (11.0M), Doximity (10.0M).
Data month: 2026-10 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.